PhOx-430

N/A

Report date: 2023/08/30 17:18:59
NMEFirst In Class

Base Information

Drug NamePhOx-430
Drug Alias NameAcetylglucosaminyltransferase V InhibitorPhOx-430
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A inhibitors
TargetsAlpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisGlioblastoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPhost'In Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesPhost'In TherapeuticsTaiho Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisGlioblastoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A